FINWIRES · TerminalLIVE
FINWIRES

Sector Update: Healthcare Stocks Mixed Pre-Bell Tuesday

By

Healthcare stocks were mixed pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.5% and the iShares Biotechnology ETF (IBB) 0.7% lower.

Natera (NTRA) has received a Category 1 recommendation from the National Comprehensive Cancer Network for Signatera-guided adjuvant atezolizumab treatment in patients with muscle-invasive bladder cancer, the company said. Natera shares were down more than 2% premarket.

Boundless Bio (BOLD) stock was up more than 79% after the company said it signed a definitive merger agreement with privately held biotech firm Serapha Bio in an all-stock merger.

Armata Pharmaceuticals (ARMP) shares were up more than 10% after the company said it has received an additional $2.5 million in non-dilutive funding under a previously announced award from the Department of Defense.

Related Articles

Sectors

Sector Update: Financial Stocks Higher Late Afternoon

Financial stocks were advancing in late Monday afternoon trading, with the NYSE Financial Index rising 0.6% and the State Street Financial Select Sector SPDR ETF (XLF) increasing 0.5%.The Philadelphia Housing Index shed 1.1%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) gained 1.3%.Bitcoin (BTC-USD) was adding 0.3% to $64,280, and the yield for 10-year US Treasuries rose 5.8 basis points to 4.509%.In corporate news, Carlyle (CG) is working with its portfolio managers to proactively evaluate and then possible de-risk assets from weather-related damages, Bloomberg reported. Carlyle shares were down 0.3%.Morgan Stanley (MS) has identified two sites within the city of Dallas for a phased approach to establishing a large-scale operational hub, according to a city document. Morgan Stanley shares rose 1.8%.Lloyds (LYG) is preparing for a potential bid to buy Aldermore, which has been put up for sale by its parent company FirstRand Group, Sky News reported. Lloyds shares climbed up 3.5%.Robinhood (HOOD) shares fell 2.2% after the company said it plans to offer $2 billion worth of convertible senior notes due 2029 in a private placement.

$CG$HOOD$LYG$MS
Sectors

Sector Update: Tech Stocks Advance Late Afternoon

Tech stocks were higher late Monday afternoon, with the State Street Technology Select Sector SPDR ETF (XLK) rising 0.1% and the State Street SPDR S&P Semiconductor ETF (XSD) adding 1.6%.The Philadelphia Semiconductor index rose 1.3%.In corporate news, Micron Technology (MU) shares gained 5% after it said Monday it is collaborating with Anthropic for memory and storage AI architecture design, product supply, and enterprise adoption of Claude, alongside an investment in Anthropic's series H funding round.Dell (DELL) shares climbed 1.6% after it introduced the PowerEdge XE8812, a new server designed to handle large AI-computing workloads and built with Nvidia's (NVDA) Vera Rubin platform.Alphabet's (GOOGL) Google DeepMind data scientist and Nobel Prize winner John Jumper is leaving to join Amazon (AMZN) and Alphabet-backed Anthropic, he said Friday. Alphabet shares were down 5.2%.STMicroelectronics (STM) shares rose 1.6% after the company said it released a new 3-dimensional light detection and ranging module designed for AI applications on small computing devices.

$DELL$GOOGL$MU$STM
Sectors

Sector Update: Healthcare Stocks Rise Late Afternoon

Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 0.9% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.8%.The iShares Biotechnology ETF (IBB) climbed 1.7%.In corporate news, AbbVie (ABBV) has agreed to acquire Apogee Therapeutics (APGE) in an all-cash deal worth about $10.9 billion, as the drugmaker looks to boost its immunology portfolio and accelerate its clinical presence in the respiratory segment. AbbVie shares jumped past 6%, and Apogee surged 46%.Regenxbio (RGNX) shares jumped 18% after it said the US Food and Drug Administration has agreed on the next steps for a potential accelerated approval of Navsunli, its experimental gene therapy for Mucopolysaccharidosis II, following discussions related to its appeal of a complete response letter issued in February.Jaguar Health (JAGX) shares climbed 16% after the firm said Monday its board has started a process to explore strategic alternatives to maximize shareholder value.Vivos Therapeutics (VVOS) shares fell 14% after it said Monday it has extended its strategic financing agreement with Streeterville Capital through Aug. 31, giving it additional time to complete planned capital-raising efforts.

$ABBV$APGE$JAGX$RGNX$VVOS